PPARGC1A and neoplasm: miR-23a then directly targets and reduces the expression of PGC1A (encoding PPARG coactivator 1 alpha) and G6PC (encoding glucose-6-phosphatase), leading to a decrease in glucose production, which might ultimately contribute to the survival of tumor cells under hypoxic conditions [38].